[1] |
Ciofu O, Rojo-Molinero E, Macià MD , et al. Antibiotic treatment of biofilm infections[J]. APMIS, 2017,125(4):304-319.
|
[2] |
Beikler T, Flemmig TF . Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures[J]. Periodontol, 2015,55(1):87-103.
|
[3] |
Wu H, Moser C, Wang H , et al. Strategies for combating bacterial biofilm infections[J]. Int J Oral Sci, 2015,7(1):1-7.
|
[4] |
Vilar G, Tulla-Puche J, Albericio F . Polymers and drug delivery systems[J]. Curr Drug Deliv, 2012,9(4):367-394.
|
[5] |
Luo M, Jia YY, Jing ZW , et al. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori[J]. Colloids Surf B Biointerfaces, 2018,164:11-19.
|
[6] |
Wei M, Gao Y, Li X , et al. Stimuli-responsive polymers and their applications[J]. Polym Chem, 2017,8(1):127-143.
|
[7] |
Balamuralidhara V, Pramodkumar TM, Srujana N , et al. pH sensitive drug delivery systems: a review[J]. Am J Drug Discov Dev, 2011,1(1):24-48.
|
[8] |
Marsh PD . Controlling the oral biofilm with antimicrobials[J]. J Dent, 2010,38(Suppl 1):11-15.
|
[9] |
Horev B, Klein MI, Hwang G , et al. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence[J]. ACS Nano, 2015,9(3):2390-2404.
|
[10] |
He X, Li J, An S , et al. pH-sensitive drug-delivery systems for tumor targeting[J]. Ther Deliv, 2013,4(12):1499-1510.
|
[11] |
Yang KN, Zhang CQ, Wang W , et al. pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment[J]. Cancer Biol Med, 2014,11(1):34-43.
|
[12] |
Liu J, Huang Y, Kumar A , et al. pH-sensitive nano-systems for drug delivery in cancer therapy[J]. Biotechnol Adv, 2014,32(4):693-710.
|
[13] |
Wang Z, Deng X, Ding J , et al. Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: a review[J]. Int J Pharm, 2018,535(1/2):253-260.
|
[14] |
Xiao J, Klein MI, Falsetta ML , et al. The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm[J]. PLoS Pathog, 2012,8(4):e1002623.
|
[15] |
Marsh PD . Understanding Dental Caries[M]. Paris:Springer International Publishing, 2016: 41-52.
|
[16] |
Zhu YJ, Chen F . pH-responsive drug-delivery systems[J]. Chem Asian J, 2015,10(2):284-305.
|
[17] |
Wicki A, Witzigmann D, Balasubramanian V , et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications[J]. J Control Release, 2015,200:138-57.
|
[18] |
Kanamala M, Wilson WR, Yang M , et al. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review[J]. Biomaterials, 2016,85:152-167.
|
[19] |
Kanizaj TF, Kunac N . Helicobacter pylori: future perspectives in therapy reflecting three decades of experience[J]. World J Gastroenterol, 2014,20(3):699-705.
|
[20] |
Lopes D, Nunes C, Martins MC , et al. Eradication of Helicobacter pylori: past, present and future[J]. J Control Release, 2014,189(36):169-186.
|
[21] |
Jing ZW, Jia YY, Wan N , et al. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori[J]. Biomaterials, 2016,84:276-285.
|
[22] |
Nguyen S, Hiorth M . Advanced drug delivery systems for local treatment of the oral cavity[J]. Ther Deliv, 2015,6(5):595-608.
|
[23] |
Bowen WH . The stephan curve revisited[J]. Odontology, 2013,101(1):2-8.
|
[24] |
Zhou J, Horev B, Hwang G , et al. Characterization and optimization of pH-responsive polymer nanoparticles for drug delivery to oral biofilms[J]. J Mater Chem B, 2016,4(18):3075-3085.
|
[25] |
Riekhof WR, Nickerson KW . Quorum sensing in Candida albicans: farnesol versus farnesoic acid[J]. FEBS lett, 2017,591(12):1637-1640.
|
[26] |
Ma L, Liu M, Liu H , et al. In vitro cytotoxicity and drug release properties of pH- and temperature-sensitive core-shell hydrogel microspheres[J]. Int J Pharm, 2010,385(1):86-91.
|
[27] |
Dong Y, Ye H, Liu Y , et al. pH dependent silver nanoparticles releasing titanium implant: a novel therapeutic approach to control peri-implant infection[J]. Colloids Surf B Biointerfaces, 2017,158:127-136.
|
[28] |
Gandhi K, Maganti RS, Kaur H , et al. Formulation and evaluation of sol-gel drug delivery system for intracanal pH sensitive controlled delivery of chlorhexidine[J]. J Clin Diagn Res, 2017,11(4):ZC68-ZC72.
|
[29] |
Owens GJ, Singh RK, Foroutan F , et al. Sol-gel based materials for biomedical applications[J]. Prog Mater Sci, 2016,77:1-79.
|
[30] |
Harish NM, Prabhu P, Charyulu RN , et al. Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis[J]. Indian J Pharm Sci, 2009,71(4):421-427.
|